Improving research capacity for infectious diseases in Liberia
BU-UL Partnership to Enhance Emerging Epidemic Virus Research in Liberia (BULEEVR)
This study is all about helping local scientists in Liberia get better at studying and responding to diseases like Ebola, so they can quickly help their communities when new outbreaks happen.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10615074 on NIH RePORTER |
What this research studies
This research aims to enhance the ability to conduct studies on emerging infectious diseases in Liberia, particularly in response to outbreaks like Ebola. It focuses on building local research infrastructure, training Liberian scientists, and establishing protocols for rapid response during epidemics. By fostering education and collaboration, the project seeks to ensure that local researchers can effectively engage with their communities and lead trials when new diseases emerge. The ultimate goal is to create a sustainable research environment that benefits both local and regional health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals living in Liberia who are affected by or at risk for infectious diseases.
Not a fit: Patients outside of Liberia or those not affected by infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the speed and effectiveness of responses to infectious disease outbreaks in Liberia.
How similar studies have performed: Other research initiatives aimed at building local research capacity in response to infectious diseases have shown promise, indicating that this approach could be effective.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Henderson, Andrew J — Boston University Medical Campus
- Study coordinator: Henderson, Andrew J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.